|
1
|
David F and Jacques F: The global and
regional burden of cancer. World Cancer Report 2014. Bernard WS and
Christopher PD: International Agency for Research on Cancer; Paris:
pp. 16–53. 2014
|
|
2
|
Llovet JM: Updated treatment approach to
hepatocellular carcinoma. J Gastroenterol. 40:225–235. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Villanueva A: Rethinking future
development of molecular therapies in hepatocellular carcinoma: A
bottom-up approach. J Hepatol. 59:392–395. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Amann T, Maegdefrau U, Hartmann A, Agaimy
A, Marienhagen J, Weiss TS, Stoeltzing O, Warnecke C, Schölmerich
J, Oefner PJ, et al: GLUT1 expression is increased in
hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol.
174:1544–1552. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zona S, Bella L, Burton MJ, de Nestal
Moraes G and Lam EW: FOXM1: An emerging master regulator of DNA
damage response and genotoxic agent resistance. Biochim Biophys
Acta. 1839:1316–1322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu QF, Liu C, Tai MH, Liu D, Lei L, Wang
RT, Tian M and Lü Y: Knockdown of FoxM1 by siRNA interference
decreases cell proliferation, induces cell cycle arrest and
inhibits cell invasion in MHCC-97H cells in vitro. Acta Pharmacol
Sin. 31:361–366. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park HJ, Gusarova G, Wang Z, Carr JR, Li
J, Kim KH, Qiu J, Park YD, Williamson PR, Hay N, et al:
Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med.
3:21–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai
MH, Liu HC, Zhang RY and Liu C: FoxM1 overexpression promotes
epithelial-mesenchymal transition and metastasis of hepatocellular
carcinoma. World J Gastroenterol. 21:196–213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Davis DB, Lavine JA, Suhonen JI,
Krautkramer KA, Rabaglia ME, Sperger JM, Fernandez LA, Yandell BS,
Keller MP, Wang IM, et al: FoxM1 is up-regulated by obesity and
stimulates beta-cell proliferation. Mol Endocrinol. 24:1822–1834.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cui J, Shi M, Xie D, Wei D, Jia Z, Zheng
S, Gao Y, Huang S and Xie K: FOXM1 promotes the warburg effect and
pancreatic cancer progression via transactivation of LDHA
expression. Clin Cancer Res. 20:2595–2606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia L, Mo P, Huang W, Zhang L, Wang Y, Zhu
H, Tian D, Liu J, Chen Z, Zhang Y, et al: The
TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes
HCC proliferation and resistance to apoptosis. Carcinogenesis.
33:2250–2259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu M, Dai B, Kang SH, Ban K, Huang FJ,
Lang FF, Aldape KD, Xie TX, Pelloski CE, Xie K, et al: FoxM1B is
overexpressed in human glioblastomas and critically regulates the
tumorigenicity of glioma cells. Cancer Res. 66:3593–3602. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Laoukili J, Stahl M and Medema RH: FoxM1:
At the crossroads of ageing and cancer. Biochim Biophys Acta.
1775:92–102. 2007.PubMed/NCBI
|
|
16
|
Yu M, Tang Z, Meng F, Tai M, Zhang J, Wang
R, Liu C and Wu Q: Elevated expression of FoxM1 promotes the tumor
cell proliferation in hepatocellular carcinoma. Tumour Biol.
37:1289–1297. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu C, Liu D, Zhang Y, Lou G, Huang G, Chen
B, Shen X, Gao M, Gong W, Zhou P, et al: LXRα-mediated
downregulation of FOXM1 suppresses the proliferation of
hepatocellular carcinoma cells. Oncogene. 33:2888–2897. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kopanja D, Pandey A, Kiefer M, Wang Z,
Chandan N, Carr JR, Franks R, Yu DY, Guzman G, Maker A, et al:
Essential roles of FoxM1 in Ras-induced liver cancer progression
and in cancer cells with stem cell features. J Hepatol. 63:429–436.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goda N and Kanai M: Hypoxia-inducible
factors and their roles in energy metabolism. Int J Hematol.
95:457–463. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim JW, Tchernyshyov I, Semenza GL and
Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase
kinase: A metabolic switch required for cellular adaptation to
hypoxia. Cell Metab. 3:177–185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Semenza GL, Roth PH, Fang HM and Wang GL:
Transcriptional regulation of genes encoding glycolytic enzymes by
hypoxia-inducible factor 1. J Biol Chem. 269:23757–23763.
1994.PubMed/NCBI
|
|
22
|
Wierstra I and Alves J: FOXM1, a typical
proliferation-associated transcription factor. Biol Chem.
388:1257–1274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kroemer G and Pouyssegur J: Tumor cell
metabolism: Cancer's Achilles' heel. Cancer Cell. 13:472–482. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han T, Kang D, Ji D, Wang X, Zhan W, Fu M,
Xin HB and Wang JB: How does cancer cell metabolism affect tumor
migration and invasion? Cell Adh Migr. 7:395–403. 2013. View Article : Google Scholar : PubMed/NCBI
|
